
BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $8.14 | Prev. Close $7.79 | Circuit Range N/A |
Day Range $8.06 - $8.16 | Year Range $0.61 - $29.40 | Volume 481 |
Average Traded $8.13 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
Day | Open | Close | Change % |
---|---|---|---|
11-Sep-25 | $8.14 | $8.16 | +4.75% |
10-Sep-25 | $7.93 | $7.79 | -0.19% |
05-Sep-25 | $7.80 | $7.80 | +1.36% |
04-Sep-25 | $7.96 | $7.70 | -7.17% |
03-Sep-25 | $8.29 | $8.29 | -1.95% |
02-Sep-25 | $7.84 | $8.46 | +8.74% |
29-Aug-25 | $7.75 | $7.78 | +4.78% |